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Abstract 
 
Objective. Obesity is associated with insulin resistance and type 2 diabetes, although the 
mechanisms linking these pathologies remain undetermined.  Recent studies in rodent models 
revealed endoplasmic reticulum (ER) stress in adipose and liver tissues and demonstrated that 
ER stress could cause insulin resistance.  Therefore, we tested whether these stress pathways 
were also present in obese human subjects and/or regulated by weight loss.   
Research Design and Methods.  Eleven obese men and women (BMI: 51.3 ± 3.0 kg/m
2
) were 
studied before and 1 year after gastric bypass (GBP) surgery.  We examined systemic insulin 
sensitivity using hyperinsulinemic-euglycemic clamp studies before and after surgery and 
collected subcutaneous adipose and liver tissues to examine ER stress markers.  
Results.  Subjects lost 39 9% body weight at 1 year after GBP surgery (p<0.001), which was 
associated with a marked improvement in hepatic, skeletal muscle and adipose tissue insulin 
sensitivity.  Markers of ER stress in adipose tissue significantly decreased with weight loss.  
Specifically, Grp78 and spliced XBP-1 mRNA levels were reduced, as were phosphorylated 
eIF2  and stress kinase JNK1 (all p values <0.05).  Liver sections from a subset of subjects 
showed intense staining for Grp78 and phosphorylated eIF2  before surgery, which was reduced 
in post-GBP sections.  
Conclusions. This study presents important evidence that ER stress pathways are present in 
selected tissues of obese humans, and that these signals are regulated by marked weight loss and 
metabolic improvement.  Hence, this suggests the possibility of an integral relationship between 
obesity-related ER stress and metabolic dysfunction in obese humans. 
Introduction  
Increased adiposity is associated with a group of chronic metabolic disorders, including insulin 
resistance, type 2 diabetes, and nonalcoholic fatty liver disease [1].  The prevalence of this 
cluster of abnormalities has increased significantly in the past few decades following the marked 
rise of obesity worldwide [2, 3].  The mechanisms responsible for the emergence of these 
disorders have been an intense area of investigation.  In the past decade it was recognized and 
established that chronic inflammatory and stress responses are a central feature of obesity, 
insulin resistance, and type 2 diabetes and contribute to the metabolic imbalance [4].  However, 
the pathways and mechanisms giving rise to the chronic inflammatory responses remain to be 
elucidated.  
 
Recently, we have identified endoplasmic reticulum (ER) dysfunction as a significant contributor 
to the development of experimental insulin resistance in obese tissues [5]. The ER is a critical 
intracellular organelle that coordinates the synthesis, folding, and trafficking of proteins.  All 
transmembrane and secreted proteins pass through the ER en route to cellular destinations; 
proteins that fail to fold into proper structures are removed from the ER through degradation.  
Under stress conditions, unfolded proteins accumulate in the ER and initiate an adaptive 
response known as the unfolded protein response (UPR).  The UPR is initiated by three ER 
transmembrane sensors (namely PERK (PKR-like ER-regulated kinase), IRE-1 (inositol-
requiring enzyme-1), and ATF-6 (activating transcription factor-6) which activate an adaptive 
response that results in cessation of protein translation and transcriptional increase in protein-
folding chaperones and ER-associated degradation genes [6].  If the stress is too severe, the UPR 
may also induce cellular apoptosis through several different mechanisms involving the various 
branches of the UPR. In mouse models of obesity, ER stress is present in liver and adipose 
tissues, as evidenced by increased activity of both the IRE-1 and PERK branches [7].  The UPR 
is also able to induce activation of the JNK pathway and thereby inhibit insulin signaling through 
the subsequent phosphorylation and/or degradation of IRS1 [7-9].  Data obtained from mouse 
models demonstrate that genetically compromised ER folding capacity induces ER stress, 
activates JNK and leads to whole body insulin resistance in the mouse [7].  In contrast, 
enhancing ER capacity in obese mice through the use of chemical or molecular chaperones 
relieves ER stress in adipose tissue and liver, reduces intrahepatic fat accumulation, and restores 
glucose homeostasis [10]. 
 
Although ER stress is associated with obesity and metabolic dysfunction in rodent models, the 
importance of ER stress in the pathogenesis of obesity-related metabolic disease and the 
potential regulation of ER function by weight loss in human subjects is not known. Therefore, 
the purpose of the present study was to evaluate the effect of marked weight loss induced by 
gastric bypass (GBP) surgery, on insulin sensitivity and ER stress in key metabolic tissues in 
obese human subjects. A euglycemic-hyperinsulinemic clamp procedure, in conjunction with 
stable isotopically labeled tracer infusions, was used to assess insulin action in liver, skeletal 
muscle and adipose tissue, and UPR markers from among the three response branches were 





Research Design and Methods 
Subjects and Gastric bypass surgery 
Eleven obese subjects  (mean BMI: 51.3 ± 3.0 kg/m
2
; 2 men and 9 women) who were scheduled 
to undergo GBP surgery participated in this study. All subjects completed a comprehensive 
medical evaluation, which included a detailed history and physical examination, routine blood 
tests, and a 12-lead electrocardiogram. No subjects had diabetes, other metabolic diseases, or 
were taking medications that affect insulin action or glucose and fatty acid metabolism. All 
subjects gave their written informed consent before participating in this study, which was 
approved by the Human Research Protection Office and the Center for Applied Research 
Sciences Advisory Committee of Washington University School of Medicine in St. Louis, MO. 
 
All GBP procedures were performed by the same surgeon (J.C.E.) using standard surgical 
techniques.  All patients had an open GBP procedure, which involved constructing a small (~20 
mL) proximal gastric pouch by stapling across the stomach.  A 150 cm Roux-Y limb was 
constructed by transecting the jejunum 30 cm distal to the ligament of Treitz and creating a 
jejunojejunostomy 150 cm distal to the transection.  
 
Metabolic Studies and Sample Analyses 
Insulin sensitivity was examined by using the hyperinsulinemic-euglycemic clamp procedure in 
10 of the 11 subjects before and one year after GBP surgery. Subjects were admitted to the 
Intensive Research Unit at Washington University School of Medicine on the evening before the 
clamp procedure.  The following morning, after subjects fasted overnight, a one-stage 




H2]palmitate were infused for 6 hours (0-3 h basal period followed by 3-6 h insulin infusion at a 
rate of 15 mU·m
-2
 body surface area [BSA]·min
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 for 5 min. Euglycemia was maintained at a 
blood glucose concentration of approximately 5.6 mmol/L (100 mg/dL) throughout the clamp 
procedure by infusing 20% dextrose enriched to 2.5% with [6,6-
2
H2]glucose. Blood samples 
were obtained before beginning the tracer infusion to determine background plasma glucose and 
palmitate tracer-to-tracee ratios (TTRs), and every 10 min during the final 30 min of the basal 
period and of the clamp procedure to determine glucose, and insulin concentrations and substrate 
kinetics.  Plasma insulin was determined by a radioimmunoassay and plasma glucose and 
palmitate tracer to tracee ratios were determined by using gas chromatography-mass 
spectroscopy (GC-MS; MSD 5973 system with capillary column; Hewlett-Packard; Palo Alto, 
CA), as previously described [11, 12]. Glucose and palmitate kinetics were determined by using 
Steele’s equation for steady-state conditions [13, 14] and hepatic insulin sensitivity was 
determined by the reciprocal of the Hepatic Insulin Resistance Index (10000/(basal glucose Ra in 
µmol/kg/min X basal insulin concentration in mU/L), as previously described [15, 16]. 
 
Subcutaneous abdominal adipose tissue samples were collected during basal postabsorptive 
conditions in all subjects by using a 14-gauge needle; samples were immediately frozen in liquid 
nitrogen. Liver tissue samples were obtained by needle biopsy during GBP surgery and by 




mRNA Isolation and quantitative PCR    
Frozen adipose tissue samples were homogenized in TRIzol Reagent (Invitrogen) for total RNA 
isolation according to the manufacturer’s protocol.  cDNA synthesis was performed using 1 µg 
of sample RNA reverse transcribed with the high capacity cDNA archive system (Applied 
Biosystems, Foster City, CA). Real-time, quantitative PCR was performed using SybrGreen 
reagent in the ABI 7300 Real-Time PCR system (Applied Biosystems) to determine the mRNA 
levels of the following genes in adipose tissue samples obtained before and after gastric by-pass 
surgery: 18S, CHOP, sXBP, Grp78, and IL-6.  Primer sequences used to detect these human 
genes are listed below. 
 
hu 18S For GTAACCCGTTGAACCCCATT 
hu 18S Rev CCATCCAATCGGTAGTAGCG 
  
hu Grp78 For CATCACGCCGTCCTATGTCG 
hu Grp78 Rev CGTCAAAGACCGTGTTCTCG 
  
hu sXBP For GGTCTGCTGAGTCCGCAGCAGG 
hu sXBP Rev GGGCTTGGTATATATGTGG 
  
hu CHOP For GGAGAACCAGGAAACGGAAAC 
hu CHOP Rev TCTCCTTCATGCGCTGCTTT 
  
hu IL-6 For AAATTCGGTACATCCTCGACGG 
hu IL-6 Rev GGAAGGTTCAGGTTGTTTTCTGC 
 
Protein Isolation, antibodies and Western blotting 
Frozen adipose tissue samples were homogenized in lysis buffer containing 25 mM Tris-HCl 
(pH7.4), 10 mM Na3VO4, 100 mM NaF, 50 mM Na4P2O7, 10 mM EGTA, 10 mM EDTA, 1% 
NP-40 with protease inhibitors (Sigma). After homogenization, the tissue lysate was centrifuged 
at 4,000 rpm for 15 minutes at 4°C followed by 14,000 rpm for 20 mins at 4°C.  Eighty µg total 
tissue protein was used for direct immunoblotting. Rabbit polyclonal anti-p-eIF2  antibody 
(Invitrogen, #44728G) was used at 1:1000 dilution; mouse monoclonal anti-p-JNK (Cell 
Signaling, #9251) was used at 1:1000 dilution; rabbit polyclonal anti-calnexin (Stressgen) was 
used at 1:1000 dilution; -tubulin (Santa Cruz, #8104) was used at 1:1000 dilution. Horseradish 
peroxidase (HRP)-linked anti-mouse, or anti-rabbit secondary antibody (GE Healthcare) was 
used at 1:4000 dilution. 
 
Immunohistochemical examination of liver sections 
Liver biopsy specimens were evaluated for steatosis and inflammation by hematoxylin and eosin 
staining and for markers of ER stress by using immunohistochemistry.  Human liver sections 
were subjected to routine deparafinization/hydration process and blocked with goat serum 
albumin for 1 hour at room temperature. Primary antibody incubation at 1:50 concentration was 
performed overnight at 4
o
C. After primary antibody incubation, sections were washed with PBS, 
and incubated with secondary antibody at 1:200 dilution for 60 minutes. At the end of the 
secondary antibody incubation sections were washed with PBS followed by application of 
mounting solution containing DAPI (Vector Lab). Secondary antibodies used in the current study 
were FITC- or texas-red conjugated anti-rabbit IgG (Santa Cruz). Negative controls included 
omission of the primary antibody.  Quantification of immunohistochemical staining was 
performed using Axiovision Software and is represented as relative intensity of  6-9 areas per 
slide.  
 
Selection of UPR markers 
We chose UPR markers from among the three branches that respond to ER stress. The 
transmembrane kinase PERK phosphorylates eukaryotic elongation initiation factor 2  (eIF2 ), 
leading to inhibition of general protein translation.  As a result of alternative translation, the pro-
apoptotic transcription factor C/EBP homologous protein (CHOP) is induced.  IRE-1 activates 
the stress kinase c-jun N-terminal kinase1 (JNK1) and also possesses endoribonuclease activity, 
which splices an intron from the mRNA of X-box binding protein-1 (XBP-1), creating an 
activated transcription factor.  Spliced XBP-1 (sXBP-1), along with active ATF-6, translocates to 
the nucleus and induces expression of protein chaperone genes. One well-known target of both 
of these transcription factors is the chaperone glucose-regulated protein 78 (Grp78).  
 
Statistical analyses 
Insulin sensitivity and patient information data sets were normally distributed according to the 
Kolmogorov-Smirnov test, so that comparisons between subjects before and after weight loss 
were performed using parametric procedures.  The statistical significance of the effect of insulin 
infusion on substrate metabolism before and after weight loss was analyzed by using the 
Student’s t-test for paired samples. Results are presented as means ±SEM. All reported p-values 




Study subject characteristics and insulin sensitivity 
On average, subjects lost ~40% of their initial body weight at 1 year after GBP surgery (Table 
1).  Weight loss caused a marked decrease in plasma glucose and insulin concentrations and in 
intrahepatic fat content (Table 1).  The Hepatic Insulin Sensitivity Index (HISI) value was 160% 
greater 1 year after than before GBP surgery (p<0.01) (Figure 1A).  Insulin infusion during the 
clamp procedure increased plasma insulin concentration from 18.7±3.1to 43.6±4.2 mU/L before 
and from 4.9±0.8 to 27.0±1.5 mU/L 1 year after GBP surgery.  Plasma glucose concentration 
during insulin infusion were 97.7±1.7 and 99.6±1.9 mg/dL during the clamp procedure 
performed before and after weight loss, respectively. Insulin infusion caused an increase in 
glucose Rd from 1081±69 to 1418±108 µmol/min before GBP surgery and from 813±57 to 
1666±171 µmol/min 1 year after GBP surgery. The increase in glucose Rd during insulin 
infusion was 200% greater after than before weight loss (p<0.01) (Figure 1B). Insulin infusion 
caused a decrease in palmitate Ra from 161±13 µmol/ min to 61±14 µmol/min before GBP 
surgery and from 105±9 to 21±4 µmol/min 1 year after GBP surgery. Insulin-mediated 
suppression of palmitate Ra was 23% greater 1 year after than before weight loss (p<0.01) 
(Figure 1C).  Taken together these data demonstrate marked metabolic improvement in subjects 
following weight reduction by GBP surgery.  
 
Adipose tissue expression and regulation of UPR-related genes 
The expression of UPR induced genes in subcutaneous abdominal adipose tissue was evaluated 
in all 11 subjects before and 1 year after GBP surgery. We first examined the splicing of the 
XBP-1 gene, a critical transcription factor and indicator of ER stress and adaptive responses.  
Following GBP, there was an average 47.5% reduction (p=0.04) in spliced XBP-1 mRNA 
compared to levels in pre-GBP tissues (Figure 2C).  When examined individually, sXBP-1 levels 
were decreased in 9 of the 11 subjects (Figure 2A,B).  Next, we examined the expression of 
GRP78 mRNA as this chaperone can be targeted by sXBP-1 and also by ATF-6, the second 
transcription factor regulating UPR. As seen in Figure 3, the levels of Grp78 mRNA were 
significantly decreased in post-GBP tissues, with an average 40.1% reduction in mRNA post-
GBP (p=0.01).  When examined individually, decreased Grp78 gene expression was evident in 
7/11 subjects (Figure 3A,B) suggesting that its regulation may be greater in variability than 
sXBP-1. In contrast, adipose tissue CHOP expression was not significantly different between the 
samples collected before or after surgery (Figure 4).  Interestingly, in rodent models of obesity, 
we also did not detect a significant regulation of CHOP mRNA expression between lean and 
obese WAT (unpublished results).  Adipose tissue IL-6 expression was determined in order to 
compare the UPR changes to a well-established inflammatory alteration.  Earlier studies have 
shown that IL-6 expression is significantly and consistently down-regulated in adipose tissue 
after weight loss [17-21].  Consistent with these observations, IL-6 mRNA levels were also 
significantly reduced in 8/11 subjects following GBP (Figure 4).  
 
Regulation of biochemical markers of ER stress in adipose and liver  
The presence of tissue ER stress in obesity in rodents is best evaluated by the phosphorylation of 
PERK, IRE-1, or eIF2  and stimulation of JNK activity, as these are more proximal measures of 
UPR activity [7].  Since there are no antibodies that can detect the phosphorylated form of PERK 
or IRE-1 in humans yet, we first measured the phosporylated form of eIF2  in adipose tissue 
before and after GBP.  Figure 5 reveals the presence of robust eIF2  phosphorylation in adipose 
tissue in all obese subjects.  Remarkably, there was a significant reduction in the phosphorylation 
of adipose tissue eIF2  after GBP surgery, which was observed in all of the subjects studied 
(p<0.0001).  We also examined the activity of JNK, which can be activated through the IRE-1 
branch of the UPR during ER stress.  JNK activation, as determined by phosphorylation of the 
JNK1 isoform, was detectable in the obese subjects prior to GBP surgery.  As shown in Figure 
5C, JNK phosphorylation also significantly decreased in adipose tissue post-GBP surgery. Taken 
together, these observations indicate alleviation of ER stress in adipose tissue after substantial 
weight loss. 
 
In a subgroup of 4 subjects, liver biopsy samples were obtained before and 1 year after GBP 
surgery.  H&E staining of the liver sections demonstrated a 90% decrease in intrahepatic 
triglyceride content following GBP surgery (Table 1 and Figure 6A). In these limited number of 
samples, we were also able to examine the effects of weight loss on eIF2  phosphorylation and 
GRP78 protein levels by immunohistochemistry.  Immunostaining with an anti-phospho eIF2  
antibody revealed strong immunoreactivity in liver sections obtained prior to GBP (Figure 6). 
Similarly, immunostaining with an antibody against the ER chaperone GRP78 revealed strong 
staining in the obese subjects prior to GBP. Particularly, areas surrounding the lipid droplets 
revealed intense staining.  In the samples obtained after weight loss, immunoreactivity against 
both phospho-eIF2  and GRP78 was reduced either in general intensity or number of areas.  In 
some cases the signal was reduced markedly (Figure 6 and Supplemental Figure 1) and in others 
partially and with residual and scattered signal.  Although variable among subjects, these results 
indicate that similar to adipose tissue, obesity in humans may also be associated with ER stress 
in liver tissue, which is ameliorated upon weight loss.     
Discussion 
 
Recent data from studies conducted in obese rodent models have demonstrated that ER stress and 
the activation of related stress signaling pathways may be an important mechanism underlying 
insulin resistance and type 2 diabetes [5].  The results of the present study demonstrate that, in 
obese humans, ER stress is present in adipose and liver tissues and is highly regulated by weight 
loss induced by GBP surgery.   
 
Gastric bypass surgery is the most commonly performed bariatric surgical procedure in the 
United States and worldwide, and is an effective approach for achieving weight loss in obese 
patients [1].  Weight loss induced by GBP surgery improves or completely resolves most 
obesity-related medical complications and increases survival [24, 25]. We chose to investigate 
ER stress in patients who had GBP surgery so that comparisons could be made within the same 
individual before and after the metabolic improvements of extreme weight loss.  This approach 
has several important strengths. First, each individual served as his/her own control, which 
removes confounding variables that may not necessarily be accounted for if the control group 
were comprised of a different cohort.  Second, by measuring change over time within an 
individual, we are able to capture the state of the ER in flux.  This is important given the highly 
dynamic nature of the ER, which adjusts its adaptive capacity to the condition of the cells as well 
as to environmental and intrinsic stress signals, such as alterations in metabolism and body 
weight. Given the fluctuating environment of the cell and the adaptive responses of the ER, a 
solitary UPR molecule may not a reliable indicator of ER functional capacity.  Therefore, we 
measured multiple markers of ER stress to assess the different UPR pathways, ranging from 
proximal biochemical activities of the sensors, to their substrates, to the downstream 
transcriptional outcomes of target gene expression. 
 
Our data clearly demonstrate a significant weight loss-induced regulation of ER stress, as 
evidenced by the suppression of biochemical indicators of ER stress such as eIF2 and JNK 
phosphorylation, and downregulation of UPR transcriptional arms via spliced XBP1 and Grp78.  
Given a relatively small patient number, we observed a remarkably consistent effect of weight 
loss on ER stress.  It is interesting that despite marked suppression of eIF2  phosphorylation in 
adipose tissue upon weight loss, there was no change in the levels of CHOP mRNA expression, 
which is generally considered to be downstream of eIF2  phosphorylation. It is possible that 
CHOP is regulated through other signals and does not respond to changes in body weight.  In 
fact, in our recent work in rodent models comparing adipose tissue samples obtained from 
genetic and dietary models of obesity with lean controls, we did not observe any change in the 
expression levels of CHOP mRNA (unpublished results).  Nonetheless, our findings suggest that 
all branches of the UPR are potentially regulated by obesity and weight loss in humans.   
 
The mechanism responsible for weight loss-induced reduction in ER stress in our subjects is not 
known.  Potential factors may include the decrease in adipose and liver triglyceride content or 
the decrease in systemic plasma insulin and glucose concentrations.  Although it is unclear how 
these factors influence ER stress, data from in vitro studies suggest that inflammation, reactive 
oxygen species, saturated fatty acids, or hypoxia could also be involved.  These signals have all 
been shown to compromise ER folding capacity and/or induce ER stress in vitro and have also 
been described in obese, insulin resistant tissues.  Nonetheless, the in vivo physiological 
mechanisms/causes remain unknown.  
 Two recent studies utilizing lean and obese cohorts have demonstrated regulation of ER stress 
markers.  Boden et al. reported an increase in ER stress proteins and gene expression in 
subcutaneous adipose tissue in obese individuals compared to lean [22].  A second study 
measured ER stress markers within a range of BMIs and found a significant positive correlation 
with increasing BMI [23].  These data support the hypothesis that obesity leads to increased ER 
stress in adipose tissue and complements our findings of the effect of weight loss on tissue stress.  
Interestingly, recent studies have also provided evidence that ER stress pathways are activated in 
pancreatic islets in type 2 diabetes and in atherosclerotic vascular lesions [26, 27].  While this is 
a relatively young field, these observations have raised the possibility that ER dysfunction and 
the resulting stress responses may be important components of chronic metabolic diseases in a 
broader sense.  The extent to which these pathways will be relevant to human metabolic diseases, 
particularly obesity and type 2 diabetes, remains a critical but unanswered question.  
 
In summary, the results from the present study demonstrate that human obesity is associated with 
insulin resistance and ER stress in both adipose tissue and the liver.  Weight loss decreases ER 
stress and improves insulin sensitivity, suggesting the possibility that the ER is involved in 
regulating insulin action in obese humans. These findings, while correlative, are consistent with 
data from studies conducted in rodent models, which have found that obesity is associated with 
ER stress, and that ameliorating ER stress improves insulin action.  Therefore, the ER could be 
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Table 1.  Metabolic characteristics of subjects before and 1 year after gastric bypass surgery. 
 Before Surgery After Surgery 
n (M/F)  10 (2/8) 10 (2/8) 
Age  40.3 ± 2.3 41.3 ± 2.3 





)  51.3 ± 3.0 31.4 ± 2.3
*
 
Glucose (mg/dL)  98.5 ± 4.8 84.2 ± 2.2
†
 
Insulin (mU/L)  18.7 ± 3.1 4.9 ± 0.8
*
 
HOMA-IR   5.3 ± 0.9 1.6 ± 0.5
†
 
Intrahepatic fat content (%)
§
  19.5 ± 5.2 1.9 ± 2.1
*
 
Systolic blood pressure (mm/Hg)  132 ± 7 108 ± 5
*
 
Diastolic blood pressure (mm/Hg)  74 ± 3 63 ± 4
†
 
Total cholesterol (mg/dL)  160 ± 13 161 ± 9 
LDL-cholesterol (mg/dL)  85 ± 10 79 ± 6 
HDL-cholesterol (mg/dL)  48 ± 4 68 ± 5
**
 
Triglyceride (mg/dL)  135 ± 19 72 ± 9
† 
HOMA-IR= homeostasis model assessment of insulin resistance. 
§ 
Data from 4 subjects.  
Values are means ± SEM.   Value significantly different from corresponding Before Surgery 










Figure 1. Alterations in systemic insulin sensitivity in GBP subjects.   
A.) Hepatic Insulin Sensitivity Index, calculated as the reciprocal of the product of basal glucose 
production and insulin concentration, B.) insulin-stimulated glucose disposal, an index of 
skeletal muscle insulin sensitivity assessed as the relative increase in glucose uptake during 
insulin infusion, and C.) insulin-mediated suppression of palmitate rate of appearance (Ra) into 
plasma, an index of adipose tissue insulin sensitivity assessed as the relative decrease in 
palmitate Ra during insulin infusion in obese subjects before (black bars) and 1 year after (white 
bars) gastric bypass (GBP) surgery.  *Value significantly different from the Before GBP value, 
*p <0.01, **p<0.001.   
 
Figure 2.  Regulation of spliced XBP-1 mRNA in GBP subjects.  
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients  before 
and after GBP surgery, n=11.   A.) Percent change in sXBP-1 mRNA  from pre-GBP to post-
GBP levels in each individual patient.  B.) Pre and Post-GBP surgery levels of sXBP-1 mRNA 
normalized to 18S ribosomal RNA.  C.) Average mRNA levels for sXBP-1 in Pre and Post-GBP 
surgery groups.  Data indicates Mean +/- SEM.   * indicates p<0.05.  
 
Figure 3.  Regulation of Grp78 mRNA in GBP subjects.  
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients before and 
after GBP, n=11.   A.) Percent change in Grp78 mRNA  from pre-GBP levels in each individual 
patient.  B.) Pre and Post-GBP surgery levels of Grp78 mRNA normalized to 18S ribosomal 
RNA.  C.) Average mRNA levels for Grp78 in Pre and Post-GBP groups.  Data indicates Mean 
+/- SEM.   * indicates p<0.02.  
 
Figure 4.  CHOP and IL-6 mRNA levels in GBP subjects.  
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients before and 
after GBP, n=11.   A.) Percent change in CHOP and IL-6 mRNA from pre GBP levels in each 
individual patient.  B.) Pre and Post-GBP levels of CHOP and IL-6 mRNA normalized to 18S 
ribosomal RNA.  C.) Average mRNA levels for CHOP and IL-6 in Pre and Post-GBP groups.  
Data indicates Mean +/- SEM.  * indicates p<0.05.   
 
Figure 5. Adipose tissue p-eIF2α and p-JNK levels after GBP procedure.  
Protein expression levels of p-eIF2α and p-JNK in adipose tissue from patients before and after 
GBP were detected by western blot assay, followed by densitometric analysis. A.) Pre and Post-
GBP levels of p-eIF2α and p-JNK normalized to calnexin.  B.) Average levels of p-eIF2α and p-
JNK in Pre and Post-GBP groups.  C.) Immunoblot analyses of p-eIF2α and p-JNK expression 
levels in patient 67, 68 and 71 before and after GBP.  Data indicates Mean +/- SEM.   * indicates 
p<0.05.  
 
Figure 6. Liver histology and p-eIF2α and GRP78 immunoreactivity after GBP. 
Liver tissue sections from patient #67 obtained during and after gastric bypass surgery (GBP) 
were stained with H&E or with antibodies against p-eIF2  (green) or GRP78 (red). Nuclei are 
stained with DAPI (blue).  The upper panel illustrates severe steatosis in the pre-GBP sample and 
marked reduction after GBP.  Staining is particularly dense around the lipid droplets (appear 
black in the stained samples). Quantification of staining is presented as relative intensity of 
signal in before and after GBP sections. *p <0.01 
 
Supplemental Figure.  Liver tissue sections obtained from three additional subjects during and 
after gastric bypass surgery (GBP) were stained with H&E or with antibodies against p-eIF2  
(green) or GRP78 (red). The upper panel illustrates steatosis in the pre- GBP sample and marked 
reduction after GBP.  Staining is particularly dense around the lipid droplets (appear black in the 
stained samples).  Representative areas are shown for each of the samples.  Quantification of 
staining is presented as relative intensity of signal in before and after GBP sections. *p <0.01 
 
 
 
 
 
 
 
 
